APA (7th ed.) Citation

Fitchett, D., Zinman, B., Inzucchi, S. E., Wanner, C., Anker, S. D., Pocock, S., . . . Lund, S. S. (2024, July). Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: Insights from the randomized EMPA-REG OUTCOME trial. Cardiovascular Diabetology.

Chicago Style (17th ed.) Citation

Fitchett, David, Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, Stefan D. Anker, Stuart Pocock, Michaela Mattheus, Ola Vedin, and Søren S. Lund. "Effect of Empagliflozin on Total Myocardial Infarction Events by Type and Additional Coronary Outcomes: Insights from the Randomized EMPA-REG OUTCOME Trial." Cardiovascular Diabetology Jul. 2024.

MLA (9th ed.) Citation

Fitchett, David, et al. "Effect of Empagliflozin on Total Myocardial Infarction Events by Type and Additional Coronary Outcomes: Insights from the Randomized EMPA-REG OUTCOME Trial." Cardiovascular Diabetology, Jul. 2024.